Metastatic renal cancer, particularly the clear-cell histology that comprises the majority of cases, is another tumor that is inherently resistant to cytotoxic agents and has shown responsiveness to immune modulators such as IFN-α and IL-2. This evidence concerns the gene IFNA1 and neoplasm.